SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Indiva Limited (NDVAF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 26/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NDVAF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.03
Book Value / Share$0.00
Revenue / Share$0.22
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-4.97 |
$0.00 |
$-1.15M |
- |
| 2015 |
$-2.72 |
$0.00 |
$-768K |
- |
| 2016 |
$-0.05 |
$0.00 |
$-1.17M |
- |
| 2017 |
$-0.12 |
$0.00 |
$-2.98M |
- |
| 2018 |
$-0.11 |
$58.31K |
$-8.53M |
-14624.3% |
| 2019 |
$-0.14 |
$923.86K |
$-11.4M |
-1233.7% |
| 2020 |
$-0.16 |
$14.65M |
$-15.42M |
-105.3% |
| 2021 |
$-0.11 |
$32.47M |
$-15.22M |
-46.9% |
| 2022 |
$-0.08 |
$34.4M |
$-10.93M |
-31.8% |
| 2023 |
$-0.03 |
$37.57M |
$-4.92M |
-13.1% |
